Filippo de Marinis

Ripamonti, European Institute of Oncology

Papers

Total Citations

H-Index

About

Filippo de Marinis is a leading thoracic surgeon whose work centers on expanding surgical options for patients with advanced lung cancer, particularly non-small cell lung cancer (NSCLC). His major contributions lie at the intersection of modern oncology and minimally invasive surgery, demonstrating how targeted therapies and immunotherapies can transform initially unresectable tumors into operable ones. In his highly cited 2022 study (15 citations), de Marinis pioneered the concept of "rescue surgery" for patients with locally advanced or oligometastatic NSCLC who achieved significant clinical downstaging after tyrosine kinase inhibitors (TKIs) or immunotherapy. This work challenges traditional treatment paradigms and offers a potentially curative path for patients previously considered inoperable. Additionally, his 2021 case-control study (7 citations) provides crucial preliminary evidence on the safety and efficacy of robotic lobectomy for stage IIIA-N2 NSCLC following induction treatment, a notoriously complex patient population. By systematically evaluating robotic surgery in this advanced setting, de Marinis is helping to define the future role of minimally invasive techniques in multidisciplinary lung cancer care. His research is essential reading for surgeons and oncologists seeking to push the boundaries of resectability and improve outcomes for patients with aggressive thoracic malignancies.